{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:14560"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:14560","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"An investigation into the genetic background of Escherichia coli lineages containing multi-drug resistant clones","abstract":"Escherichia coli is a commensal resident of the human gastrointestinal tract that can also cause disease at multiple extra-intestinal body sites. E. coli is globally recognised as a pathogen of concern due to the high prevalence of antimicrobial resistance (AMR) present within the species. However, the prevalence of AMR is not uniform across the enormously diverse E. coli population. Some E. coli lineages remain largely susceptible to antibiotics, whilst others are resistant to many antibiotic classes and are therefore multi-drug resistant (MDR). A wide spectrum of resistance phenotypes have been observed in strains from throughout the E. coli phylogeny, meaning that the ability to acquire and accumulate resistance determinants is not an exclusively vertically-inherited trait. A simple explanation for the phylogenetic spread of MDR phenotypes could be that the lineages that encounter antibiotics more frequently are more resistant. Yet this is not the case, as multiple longitudinal studies have shown that large, stable proportions of E. coli bloodstream and urinary tract infections are caused by lineages that do not exhibit high levels of resistance. Compounding the problem, MDR E. coli are adept at colonising the gastrointestinal tracts of healthy humans who are not taking antibiotics. Studies of international travellers have documented colonisation with MDR E. coli occurring within days of arriving in AMR endemic areas.","abstract_html":"Escherichia coli is a commensal resident of the human gastrointestinal tract that can also cause disease at multiple extra-intestinal body sites. E. coli is globally recognised as a pathogen of concern due to the high prevalence of antimicrobial resistance (AMR) present within the species. However, the prevalence of AMR is not uniform across the enormously diverse E. coli population. Some E. coli lineages remain largely susceptible to antibiotics, whilst others are resistant to many antibiotic classes and are therefore multi-drug resistant (MDR). A wide spectrum of resistance phenotypes have been observed in strains from throughout the E. coli phylogeny, meaning that the ability to acquire and accumulate resistance determinants is not an exclusively vertically-inherited trait. A simple explanation for the phylogenetic spread of MDR phenotypes could be that the lineages that encounter antibiotics more frequently are more resistant. Yet this is not the case, as multiple longitudinal studies have shown that large, stable proportions of E. coli bloodstream and urinary tract infections are caused by lineages that do not exhibit high levels of resistance. Compounding the problem, MDR E. coli are adept at colonising the gastrointestinal tracts of healthy humans who are not taking antibiotics. Studies of international travellers have documented colonisation with MDR E. coli occurring within days of arriving in AMR endemic areas.","abstract_has_math":false,"creators":["Cummins, Elizabeth"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-07","date_published":"2024-07","updated_at":"2026-11-19T09:32:36Z","subjects":["QR Microbiology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["108 876B15Z"],"render_values":[{"text":"108 876B15Z","href":null,"code":true}]}],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000305753151"],"render_values":[{"text":"0000-0003-0575-3151","href":"https://orcid.org/0000-0003-0575-3151","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/14560/7/Cummins2024PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A14560","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["Cummins, Elizabeth"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000305753151"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-07-19"]},{"key":"dc:date.issued","label":"Date","values":["2024-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/14560/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["108 876B15Z"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/14560/7/Cummins2024PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Escherichia coli is a commensal resident of the human gastrointestinal tract that can also cause disease at multiple extra-intestinal body sites. E. coli is globally recognised as a pathogen of concern due to the high prevalence of antimicrobial resistance (AMR) present within the species. However, the prevalence of AMR is not uniform across the enormously diverse E. coli population. Some E. coli lineages remain largely susceptible to antibiotics, whilst others are resistant to many antibiotic classes and are therefore multi-drug resistant (MDR). A wide spectrum of resistance phenotypes have been observed in strains from throughout the E. coli phylogeny, meaning that the ability to acquire and accumulate resistance determinants is not an exclusively vertically-inherited trait. A simple explanation for the phylogenetic spread of MDR phenotypes could be that the lineages that encounter antibiotics more frequently are more resistant. Yet this is not the case, as multiple longitudinal studies have shown that large, stable proportions of E. coli bloodstream and urinary tract infections are caused by lineages that do not exhibit high levels of resistance. Compounding the problem, MDR E. coli are adept at colonising the gastrointestinal tracts of healthy humans who are not taking antibiotics. Studies of international travellers have documented colonisation with MDR E. coli occurring within days of arriving in AMR endemic areas."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["An investigation into the genetic background of Escherichia coli lineages containing multi-drug resistant clones"]}]}],"canonical_facts":{"dc:contributor.sponsor":["wellcome_trust"],"dc:creator":["Cummins, Elizabeth"],"dc:date":["2024-07-19"],"dc:date.issued":["2024-07"],"dc:description.abstract":["Escherichia coli is a commensal resident of the human gastrointestinal tract that can also cause disease at multiple extra-intestinal body sites. E. coli is globally recognised as a pathogen of concern due to the high prevalence of antimicrobial resistance (AMR) present within the species. However, the prevalence of AMR is not uniform across the enormously diverse E. coli population. Some E. coli lineages remain largely susceptible to antibiotics, whilst others are resistant to many antibiotic classes and are therefore multi-drug resistant (MDR). A wide spectrum of resistance phenotypes have been observed in strains from throughout the E. coli phylogeny, meaning that the ability to acquire and accumulate resistance determinants is not an exclusively vertically-inherited trait. A simple explanation for the phylogenetic spread of MDR phenotypes could be that the lineages that encounter antibiotics more frequently are more resistant. Yet this is not the case, as multiple longitudinal studies have shown that large, stable proportions of E. coli bloodstream and urinary tract infections are caused by lineages that do not exhibit high levels of resistance. Compounding the problem, MDR E. coli are adept at colonising the gastrointestinal tracts of healthy humans who are not taking antibiotics. Studies of international travellers have documented colonisation with MDR E. coli occurring within days of arriving in AMR endemic areas."],"dc:format":["text"],"dc:identifier.grantnumber":["108 876B15Z"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/14560/7/Cummins2024PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/14560/"],"dc:subject":["QR Microbiology"],"dcterms:accessrights":["public"],"dc:title":["An investigation into the genetic background of Escherichia coli lineages containing multi-drug resistant clones"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000305753151"]},"updated_at":"2026-11-19T09:32:36Z"}